Literature DB >> 19808022

LKB1 regulates pancreatic beta cell size, polarity, and function.

Zvi Granot1, Avital Swisa, Judith Magenheim, Miri Stolovich-Rain, Wakako Fujimoto, Elisabetta Manduchi, Takashi Miki, Jochen K Lennerz, Christian J Stoeckert, Oded Meyuhas, Susumu Seino, M Alan Permutt, Helen Piwnica-Worms, Nabeel Bardeesy, Yuval Dor.   

Abstract

Pancreatic beta cells, organized in the islets of Langerhans, sense glucose and secrete appropriate amounts of insulin. We have studied the roles of LKB1, a conserved kinase implicated in the control of cell polarity and energy metabolism, in adult beta cells. LKB1-deficient beta cells show a dramatic increase in insulin secretion in vivo. Histologically, LKB1-deficient beta cells have striking alterations in the localization of the nucleus and cilia relative to blood vessels, suggesting a shift from hepatocyte-like to columnar polarity. Additionally, LKB1 deficiency causes a 65% increase in beta cell volume. We show that distinct targets of LKB1 mediate these effects. LKB1 controls beta cell size, but not polarity, via the mTOR pathway. Conversely, the precise position of the beta cell nucleus, but not cell size, is controlled by the LKB1 target Par1b. Insulin secretion and content are restricted by LKB1, at least in part, via AMPK. These results expose a molecular mechanism, orchestrated by LKB1, for the coordinated maintenance of beta cell size, form, and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808022      PMCID: PMC2790403          DOI: 10.1016/j.cmet.2009.08.010

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  57 in total

1.  Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet.

Authors:  Noriko Takahashi; Takuya Kishimoto; Tomomi Nemoto; Takashi Kadowaki; Haruo Kasai
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

2.  LKB1 modulates lung cancer differentiation and metastasis.

Authors:  Hongbin Ji; Matthew R Ramsey; D Neil Hayes; Cheng Fan; Kate McNamara; Piotr Kozlowski; Chad Torrice; Michael C Wu; Takeshi Shimamura; Samanthi A Perera; Mei-Chih Liang; Dongpo Cai; George N Naumov; Lei Bao; Cristina M Contreras; Danan Li; Liang Chen; Janakiraman Krishnamurthy; Jussi Koivunen; Lucian R Chirieac; Robert F Padera; Roderick T Bronson; Neal I Lindeman; David C Christiani; Xihong Lin; Geoffrey I Shapiro; Pasi A Jänne; Bruce E Johnson; Matthew Meyerson; David J Kwiatkowski; Diego H Castrillon; Nabeel Bardeesy; Norman E Sharpless; Kwok-Kin Wong
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

3.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

4.  Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia.

Authors:  E Bernal-Mizrachi; W Wen; S Stahlhut; C M Welling; M A Permutt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.

Authors:  A Woods; D Azzout-Marniche; M Foretz; S C Stein; P Lemarchand; P Ferré; F Foufelle; D Carling
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Authors:  Nabeel Bardeesy; Manisha Sinha; Aram F Hezel; Sabina Signoretti; Nathaniel A Hathaway; Norman E Sharpless; Massimo Loda; Daniel R Carrasco; Ronald A DePinho
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

7.  Transcriptional program of the endocrine pancreas in mice and humans.

Authors:  Klaus H Kaestner; Catherine S Lee; L Marie Scearce; John E Brestelli; Athanasios Arsenlis; Phillip Phuc Le; Kristen A Lantz; Jonathan Crabtree; Angel Pizarro; Joan Mazzarelli; Deborah Pinney; Steve Fischer; Elisabetta Manduchi; Christian J Stoeckert; Gerard Gradwohl; Sandra W Clifton; Juliana R Brown; Hiroshi Inoue; Corentin Cras-Méneur; M Alan Permutt
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

8.  LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.

Authors:  Angela Woods; Stephen R Johnstone; Kristina Dickerson; Fiona C Leiper; Lee G D Fryer; Dietbert Neumann; Uwe Schlattner; Theo Wallimann; Marian Carlson; David Carling
Journal:  Curr Biol       Date:  2003-11-11       Impact factor: 10.834

9.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.

Authors:  Guoqiang Gu; Jolanta Dubauskaite; Douglas A Melton
Journal:  Development       Date:  2002-05       Impact factor: 6.868

10.  Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression.

Authors:  Gabriela da Silva Xavier; Isabelle Leclerc; Aniko Varadi; Takashi Tsuboi; S Kelly Moule; Guy A Rutter
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

View more
  90 in total

1.  Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.

Authors:  Jia Nie; Chao Sun; Omar Faruque; Guangming Ye; Jia Li; Qiangrong Liang; Zhijie Chang; Wannian Yang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Depletion of intranuclear rodlets in mouse models of diabetes.

Authors:  Pavel Milman; Accalia Fu; Robert A Screaton; John M Woulfe
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

Review 3.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Primary cilia regulate mTORC1 activity and cell size through Lkb1.

Authors:  Christopher Boehlke; Fruzsina Kotsis; Vishal Patel; Simone Braeg; Henriette Voelker; Saskia Bredt; Theresa Beyer; Heike Janusch; Christoph Hamann; Markus Gödel; Klaus Müller; Martin Herbst; Miriam Hornung; Mara Doerken; Michael Köttgen; Roland Nitschke; Peter Igarashi; Gerd Walz; E Wolfgang Kuehn
Journal:  Nat Cell Biol       Date:  2010-10-24       Impact factor: 28.824

5.  mTOR links incretin signaling to HIF induction in pancreatic beta cells.

Authors:  Sam Van de Velde; Meghan F Hogan; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

6.  Identification of proliferative and mature β-cells in the islets of Langerhans.

Authors:  Erik Bader; Adriana Migliorini; Moritz Gegg; Noah Moruzzi; Jantje Gerdes; Sara S Roscioni; Mostafa Bakhti; Elisabeth Brandl; Martin Irmler; Johannes Beckers; Michaela Aichler; Annette Feuchtinger; Christin Leitzinger; Hans Zischka; Rui Wang-Sattler; Martin Jastroch; Matthias Tschöp; Fausto Machicao; Harald Staiger; Hans-Ulrich Häring; Helena Chmelova; Julie A Chouinard; Nikolay Oskolkov; Olle Korsgren; Stephan Speier; Heiko Lickert
Journal:  Nature       Date:  2016-07-11       Impact factor: 49.962

7.  LKB1 couples glucose metabolism to insulin secretion in mice.

Authors:  Accalia Fu; Karine Robitaille; Brandon Faubert; Courtney Reeks; Xiao-Qing Dai; Alexandre B Hardy; Krishana S Sankar; Svetlana Ogrel; Osama Y Al-Dirbashi; Jonathan V Rocheleau; Michael B Wheeler; Patrick E MacDonald; Russell Jones; Robert A Screaton
Journal:  Diabetologia       Date:  2015-04-16       Impact factor: 10.122

Review 8.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

Review 9.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

10.  Differential effects on β-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes.

Authors:  Sukanya Lodh; Timothy L Hostelley; Carmen C Leitch; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.